Molecular characterization of hematopoietic stem cells after in vitro amplification on biomimetic 3D PDMS cell culture scaffolds

Lisa Marx-Blümel, Christian Marx, Jürgen Sonnemann, Frank Weise, Jörg Hampl, Jessica Frey, Linda Rothenburger, Emilio Cirri, Norman Rahnis, Philipp Koch, Marco Groth, Andreas Schober, Zhao‐Qi Wang, James F. BeckScientific 2021 · DOI

TL;DR

This study introduces a novel 3D polydimethylsiloxane (PDMS) scaffold that mimics the natural bone marrow niche, significantly improving the ex vivo expansion of human hematopoietic stem cells (HSCs) while maintaining their pluripotency. By analyzing transcriptome and proteome data, the researchers identified key molecular pathways activated by these scaffolds, paving the way for more effective HSC transplantation therapies.

What Problem Does This Paper Address?

Hematopoietic stem cell transplantation (HSCT) is a life-saving treatment for various blood disorders. However, its success is often limited by the insufficient number of functional HSCs available from donors. Current methods for expanding HSCs ex vivo struggle to maintain their crucial properties of self-renewal and pluripotency, leading to rapid differentiation into less potent progenitor cells. This paper addresses the critical need for an improved ex vivo culture system that can generate a large quantity of undifferentiated HSCs, thereby enhancing the efficacy of HSCT.

Methods

The researchers developed biomimetic 3D polydimethylsiloxane (PDMS) scaffolds designed to replicate the natural bone marrow niche. These scaffolds, along with an optimized HSC culture medium, were used to culture human HSCs for 14 days. To understand the underlying mechanisms, they employed a multi-omics approach:

  • Transcriptome Analysis: RNA sequencing was performed on HSCs before and after ex vivo culture on different scaffolds (2D polystyrene, 3D PDMS, and 3D silicon oxide-coated PDMS) to identify changes in gene expression.
  • Proteome Analysis: Untargeted mass spectrometry was used to analyze the protein profiles of HSCs under the same conditions.
  • Ingenuity Pathway Analysis (IPA): This bioinformatics tool was used to interpret the transcriptome and proteome data, identifying activated or inhibited molecular signaling pathways and upstream regulators.
  • Enzyme-Linked Immunosorbent Assay (ELISA): Used to quantify the secretion of specific cytokines from cultured HSCs.
  • Seahorse Analysis: Metabolic flux analysis was conducted to measure mitochondrial respiration (OCR) and glycolysis (ECAR) of HSCs.
  • Western Blotting: Used to confirm the activation of key proteins involved in specific signaling pathways.

Datasets

The study utilized primary human CD34+ hematopoietic stem cells obtained from mobilized peripheral blood of healthy male and female donors. The data generated from transcriptome and proteome analyses were deposited in public repositories:

  • RNA-seq data: NCBI's Gene Expression Omnibus (GEO) under accession number GSE178657.
  • Proteomics data: ProteomeXchange Consortium via the PRIDE partner repository with data set identifiers PXD025849.

Key Insights and Ideas

  • 3D PDMS Scaffolds as a Superior Niche: The 3D PDMS scaffolds, mimicking the bone marrow structure, proved to be significantly more effective than standard 2D polystyrene culture for expanding undifferentiated HSCs and maintaining their long-term repopulating potential.
  • Activation of Key Signaling Pathways: The 3D PDMS environment specifically activated pathways like SREBP, HIF1α, and FOXO. These pathways are crucial for metabolic adaptation and maintaining HSC pluripotency.
  • Metabolic Adaptations for Quiescence: HSCs cultured on 3D PDMS exhibited reduced mitochondrial respiration and increased reliance on aerobic glycolysis. This metabolic shift is indicative of a more quiescent state, which is essential for preserving HSC self-renewal capacity.
  • Pro-inflammatory Response on 3D SiOn: In contrast, 3D silicon oxide-coated (SiOn) scaffolds induced a pro-inflammatory response and activated PI3K/AKT/mTOR signaling, leading to differentiation rather than expansion of undifferentiated HSCs.
  • Importance of Material Properties: The study highlights that not just the 3D structure, but also the material properties like elasticity and surface hydrophobicity of the scaffolds play a critical role in HSC behavior and expansion.

Key Results

  • Amplification of Undifferentiated HSCs: After 14 days of ex vivo culture, 3D PDMS scaffolds led to a significant increase in the total number and percentage of CD34+ cells, particularly CD34+/CD38-/CD45RA-/CD49f+/CD90+ long-term HSCs (LT-HSCs), compared to 2D PS.
  • Enhanced Clonogenic Potential: Cells cultured on 3D PDMS showed higher numbers of CFU-GEMM and BFU-E colonies, indicating a greater potential for multi-lineage differentiation and primitive erythroid progenitors, respectively.
  • Molecular Pathway Activation: IPA revealed that 3D PDMS scaffolds strongly activated SREBP1/2, HIF1α, and FOXO signaling pathways, while also promoting cholesterol metabolism.
  • Metabolic Shift: Seahorse analysis showed that cells on 3D PDMS had lower basal oxygen consumption rates (OCR) and similar extracellular acidification rates (ECAR) compared to 2D PS, suggesting a shift towards less energy-intensive metabolism.
  • Cytokine Profile: ELISA indicated that 3D PDMS cultures produced a more balanced profile of pro- and anti-inflammatory cytokines compared to 2D PS and 3D SiOn, which showed a pro-inflammatory bias.

Limitations and Future Work

  • In Vivo Repopulating Potential: While the study demonstrates successful ex vivo amplification and maintenance of LT-HSCs, the in vivo repopulating potential of these amplified HSCs needs to be further elucidated in future studies.
  • Optimizing Biomechanical Properties: The authors suggest that further optimization of the biomechanical properties of 3D PDMS scaffolds and the cell culture conditions could further enhance the activation of HIF1α and SREBP signaling for even more effective ex vivo HSC expansion.
  • Understanding Inflammation: The pro-inflammatory response observed with 3D SiOn scaffolds warrants further investigation to understand its precise mechanisms and implications for HSC behavior.

Summary updated

Abstract

Hematopoietic stem cell (HSC) transplantation is successfully applied since the late 1950s. However, its efficacy can be impaired by insufficient numbers of donor HSCs. A promising strategy to overcome this hurdle is the use of an advanced ex vivo culture system that supports the proliferation and, at the same time, maintains the pluripotency of HSCs. Therefore, we have developed artificial 3D bone marrow-like scaffolds made of polydimethylsiloxane (PDMS) that model the natural HSC niche in vitro. These 3D PDMS scaffolds in combination with an optimized HSC culture medium allow the amplification of high numbers of undifferentiated HSCs. After 14 days in vitro cell culture, we performed transcriptome and proteome analysis. Ingenuity pathway analysis indicated that the 3D PDMS cell culture scaffolds altered PI3K/AKT/mTOR pathways and activated SREBP, HIF1α and FOXO signaling, leading to metabolic adaptations, as judged by ELISA, Western blot and metabolic flux analysis. These molecular signaling pathways can promote the expansion of HSCs and are involved in the maintenance of their pluripotency. Thus, we have shown that the 3D PDMS scaffolds activate key molecular signaling pathways to amplify the numbers of undifferentiated HSCs ex vivo effectively.
BibTeX
@inproceedings{marxblumel2021molecular,
  author = {Lisa Marx-Blümel and Christian Marx and Jürgen Sonnemann and Frank Weise and Jörg Hampl and Jessica Frey and Linda Rothenburger and Emilio Cirri and Norman Rahnis and Philipp Koch and Marco Groth and Andreas Schober and Zhao‐Qi Wang and James F. Beck},
  title = {{Molecular characterization of hematopoietic stem cells after in vitro amplification on biomimetic 3D PDMS cell culture scaffolds}},
  booktitle = {Scientific},
  year = {2021},
  doi = {10.1038/s41598-021-00619-6},
}
Figure